Efficacy and safety of COX 2 inhibitors
- PMID: 12242157
- PMCID: PMC1124144
- DOI: 10.1136/bmj.325.7365.607
Efficacy and safety of COX 2 inhibitors
Comment in
-
Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Celecoxib's relative gastrointestinal safety is overstated.BMJ. 2003 Feb 8;326(7384):334; author reply 334. BMJ. 2003. PMID: 12575714 No abstract available.
Comment on
-
Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.BMJ. 2002 Sep 21;325(7365):619. doi: 10.1136/bmj.325.7365.619. BMJ. 2002. PMID: 12242171 Free PMC article.
-
Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs.BMJ. 2002 Sep 21;325(7365):624. doi: 10.1136/bmj.325.7365.624. BMJ. 2002. PMID: 12242172 Free PMC article.
References
-
- Watson DJ, Rhodes T, Cai B, Guess HA. Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis. Arch Intern Med. 2002;162:1105–1110. - PubMed
-
- Ota S, Bamba H, Kato A, Kawamoto C, Yoshida Y, Fujiwara K, et al. COX-2, prostanoids and colon cancer. Aliment Pharm Ther. 2002;16(suppl 2):102–106. - PubMed
-
- Husain SS, Szabo IL, Tamawski AS. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am J Gastroenterol. 2002;97:542–553. - PubMed
-
- Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomised controlled trial. JAMA. 2000;284:1247–1255. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials